V Income tax payable X Other financial liabilities (current) Y Other current liabilities W Provisions (current) (Presentation) Income tax payable included in “Other” as current liabilities  under Japanese GAAP has been presented separately as  “Income tax payable” under IFRS. (Presentation) Short-term finance lease liabilities and guaranty deposits  received included in “Other” as current liabilities under Japanese  GAAP have been included in “Other financial liabilities” (current)  under IFRS. (Presentation) Liabilities arising from certain sales discounts or rebates  included in “Accrued expenses” or “Other” as current liabilities  under Japanese GAAP have been included in “Provisions”  (current) under IFRS. (Presentation) “Allowance for sales rebates” presented separately as cur- rent liabilities under Japanese GAAP has been included in  “Provisions” (current) under IFRS. (Recognition and measurement) Liabilities for certain sales discounts or returns were deducted  from “Notes and accounts receivable-trade” under Japanese  GAAP. However, they have been included in “Provisions”  (current) under IFRS. Income tax payable included in “Other” as current liabilities  under Japanese GAAP has been presented separately as  “Income tax payable” under IFRS. Accrued paid absences of ¥5,327 million not recognised under  Japanese GAAP were recognised and included in “Other current  liabilities” under IFRS. Financial Section Certain liabilities included in “Accrued expenses” separately  presented as current liabilities under Japanese GAAP have  been included in “Other current liabilities” under IFRS. (Recognition and measurement) Liabilities arising from certain in-licensing agreements were  included in “Other” as current liabilities under Japanese GAAP.  However, they have been included in “Trade and other payables”  (current) under IFRS. Annual Report 2014 _  Astellas Pharma Inc.  155